| Antibody-drug conjugates for cancer therapy: chemistry to clinical implications N Dan, S Setua, VK Kashyap, S Khan, M Jaggi, MM Yallapu, SC Chauhan Pharmaceuticals 11 (2), 32, 2018 | 193 | 2018 |
| Smoking and COVID-19: adding fuel to the flame VK Kashyap, A Dhasmana, A Massey, S Kotnala, N Zafar, M Jaggi, ... International journal of molecular sciences 21 (18), 6581, 2020 | 107 | 2020 |
| Tannic acid induces endoplasmic reticulum stress-mediated apoptosis in prostate cancer PKB Nagesh, E Hatami, P Chowdhury, VK Kashyap, S Khan, BB Hafeez, ... Cancers 10 (3), 68, 2018 | 64 | 2018 |
| Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis S Singh, KK Roy, SR Khan, VK Kashyap, A Sharma, S Jaiswal, ... Bioorganic & Medicinal Chemistry 23 (4), 742-752, 2015 | 59 | 2015 |
| Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells PKB Nagesh, P Chowdhury, E Hatami, S Jain, N Dan, VK Kashyap, ... Scientific reports 10 (1), 980, 2020 | 51 | 2020 |
| Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression BB Hafeez, A Ganju, M Sikander, VK Kashyap, ZB Hafeez, N Chauhan, ... Molecular cancer therapeutics 16 (10), 2267-2280, 2017 | 51 | 2017 |
| In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine … VK Kashyap, RK Gupta, R Shrivastava, BS Srivastava, R Srivastava, ... Journal of antimicrobial chemotherapy 67 (5), 1188-1197, 2012 | 47 | 2012 |
| miRNA-205 nanoformulation sensitizes prostate cancer cells to chemotherapy PKB Nagesh, P Chowdhury, E Hatami, VKN Boya, VK Kashyap, S Khan, ... Cancers 10 (9), 289, 2018 | 45 | 2018 |
| MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer S Kumari, S Khan, SC Gupta, VK Kashyap, MM Yallapu, SC Chauhan, ... Oncogenesis 7 (2), 19, 2018 | 40 | 2018 |
| Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer VK Kashyap, Q Wang, S Setua, PKB Nagesh, N Chauhan, S Kumari, ... Journal of Experimental & Clinical Cancer Research 38 (1), 1-14, 2019 | 31 | 2019 |
| Cross-linked polyphenol-based drug nano-self-assemblies engineered to blockade prostate cancer senescence PKB Nagesh, P Chowdhury, E Hatami, S Kumari, VK Kashyap, ... ACS applied materials & interfaces 11 (42), 38537-38554, 2019 | 31 | 2019 |
| Identification and characterisation of small-molecule inhibitors of Rv3097c-encoded lipase (LipY) of Mycobacterium tuberculosis that selectively inhibit growth of bacilli in … AK Saxena, KK Roy, S Singh, SP Vishnoi, A Kumar, VK Kashyap, ... International journal of antimicrobial agents 42 (1), 27-35, 2013 | 30 | 2013 |
| Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment AE Massey, M Sikander, N Chauhan, S Kumari, S Setua, AB Shetty, ... Nanomedicine: Nanotechnology, Biology and Medicine 20, 102027, 2019 | 28 | 2019 |
| Cucurbitacin D reprograms glucose metabolic network in prostate cancer M Sikander, S Malik, N Chauhan, P Khan, S Kumari, VK Kashyap, S Khan, ... Cancers 11 (3), 364, 2019 | 28 | 2019 |
| Withania somnifera as a potential future drug molecule for COVID-19 VK Kashyap, A Dhasmana, MM Yallapu, SC Chauhan, M Jaggi Future drug discovery 2 (4), FDD50, 2020 | 27 | 2020 |
| Design, Synthesis and Biological evaluation of Bicyclic Iminosugar Hybrids: Conformational constraint as an effective tool for tailoring the selectivity of α-glucosidase inhibitors I Arora, VK Kashyap, AK Singh, A Dasgupta, B Kumar, AK Shaw Organic & Biomolecular Chemistry 12 (35), 6855-6868, 2014 | 25 | 2014 |
| Disparity in rates of HPV infection and cervical cancer in underserved US populations AR Karuri, VK Kashyap, MM Yallapu, N Zafar, SK Kedia, M Jaggi, ... Frontiers in bioscience (Scholar edition) 9, 254, 2017 | 20 | 2017 |
| Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin A Dhasmana, S Uniyal, Anukriti, VK Kashyap, P Somvanshi, M Gupta, ... Scientific reports 10 (1), 12045, 2020 | 18 | 2020 |
| Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics VK Kashyap, G Peasah-Darkwah, A Dhasmana, M Jaggi, MM Yallapu, ... Pharmaceutics 14 (3), 611, 2022 | 17 | 2022 |
| VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway VK Kashyap, N Dan, N Chauhan, Q Wang, S Setua, PKB Nagesh, S Malik, ... Cancer letters 470, 64-74, 2020 | 12 | 2020 |
Murali YallapuAssociate Professor, University of Texas Rio Grande Valley在 utrgv.edu 的电子邮件经过验证
